Coreana Cosmetics Co., Ltd

As of March 31, 2026, Coreana Cosmetics Co., Ltd carries a market capitalization of 56.70B, placing it among publicly traded companies globally. Its enterprise value stands at 46.61B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, Coreana Cosmetics Co., Ltd has 32.20M shares outstanding.

These figures are as of March 31, 2026. The price-to-sales ratio is 0.77, and the price-to-book ratio stands at 0.67.

These figures are as of March 31, 2026. The EV/Sales ratio of 0.64 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 46.61B versus a market cap of 56.70B, with the gap driven by net debt and cash on the balance sheet.

As of March 31, 2026, Coreana Cosmetics Co., Ltd maintains a current ratio of 3.01, meaning it holds 3.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 1.89, indicating elevated leverage, while an interest coverage ratio of -8.69 demonstrates limited ability to service its debt obligations.

Over the twelve months ended March 31, 2026, Coreana Cosmetics Co., Ltd posted a negative return on equity (ROE) of -8.46, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -6.86, reflecting losses generated across the asset base. The company generates approximately 439.78M in revenue per employee across its workforce of 166.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 3.19 indicates how many times Coreana Cosmetics Co., Ltd sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended March 31, 2026, Coreana Cosmetics Co., Ltd recorded an income tax benefit of -654.15M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -7.87B and -7.23B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 23, 2026, Coreana Cosmetics Co., Ltd's stock has declined approximately 51.90% over the past 52 weeks. The 50-day moving average sits at 1,337.78, while the 200-day moving average is 1,680.51.

Over the twelve months ended March 31, 2026, Coreana Cosmetics Co., Ltd generated 73.22B in revenue and converted that into -7.23B in net income, yielding earnings per share of -226.60. EBITDA reached -1.35B, while operating income came in at -3.87B.

As of March 31, 2026, Coreana Cosmetics Co., Ltd holds 11.70B in cash and equivalents against 1.60B in total debt, resulting in a net debt position of -8.46B. Total book value stands at 84.66B, with working capital of 24.25B providing operational flexibility.

Coreana Cosmetics Co., Ltd produced -2.55B in operating cash flow over the twelve months ended March 31, 2026. After subtracting -249.20M in capital expenditures, free cash flow totaled -2.80B - equivalent to -87.85 per share.

Over the twelve months ended March 31, 2026, Coreana Cosmetics Co., Ltd posted a gross margin of 34.42, reflecting its pricing power and cost economics. The operating margin of -5.28 and net profit margin of -9.87 provide insight into operational efficiency.

These figures cover the twelve months ended March 31, 2026. Free cash flow yield is negative at -4.99: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -2.05, meaning Coreana Cosmetics Co., Ltd raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Coreana Cosmetics Co., Ltd's most recent stock split took place on April 20, 2000.

As of March 31, 2026, Coreana Cosmetics Co., Ltd has an Altman Z-Score of 3.28, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.